Vimarsana
Biggest News Aggregation in the World

Page 33 - Oint Inflammation News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Oint Inflammation. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Oint Inflammation Today - Breaking & Trending Today

Drugmakers to Raise Prices on at Least 350 Drugs in US in January - Vimarsana News

Drugmakers to Raise Prices on at Least 350 Drugs in US in January

Drugmakers including Pfizer, GSK, BMS, AstraZeneca, and Sanofi plan to raise prices on more than 350 unique drugs in early January, according to data analyzed by a healthcare research firm.

Study Evaluates Alopecia Areata Features in Hispanic Population - Vimarsana News

Study Evaluates Alopecia Areata Features in Hispanic Population

In the study, the most common comorbidity in patients overall was atopy, including allergic rhinitis, asthma, and/or atopic dermatitis.

Metabolic Syndrome May Promote Gout in Young Men - Vimarsana News

Metabolic Syndrome May Promote Gout in Young Men

Population-based studies suggest that managing metabolic syndrome may help to prevent gout in younger adults.

Rheumatology Workforce Shortage Demands Multipronged Approach - Vimarsana News

Rheumatology Workforce Shortage Demands Multipronged Approach

Members of the American College of Rheumatology's Workforce Solutions Committee outlined a multitude of ways in which the society aims to marshal local, regional, and national resources and programs.

Ustekinumab Matches TNF Inhibitors for PsA in Real-World Study - Vimarsana News

Ustekinumab Matches TNF Inhibitors for PsA in Real-World Study

A real-world study comparing the interleukin-12/23 inhibitor ustekinumab with tumor necrosis factor inhibitors for psoriatic arthritis found similar rates of treatment persistence and efficacy.